Your browser doesn't support javascript.
loading
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level.
John, Lukas; Poos, Alexandra M; Brobeil, Alexander; Schinke, Carolina; Huhn, Stefanie; Prokoph, Nina; Lutz, Raphael; Wagner, Barbara; Zangari, Maurizio; Tirier, Stephan M; Mallm, Jan-Philipp; Schumacher, Sabrina; Vonficht, Dominik; Solé-Boldo, Llorenç; Quick, Sabine; Steiger, Simon; Przybilla, Moritz J; Bauer, Katharina; Baumann, Anja; Hemmer, Stefan; Rehnitz, Christoph; Lückerath, Christian; Sachpekidis, Christos; Mechtersheimer, Gunhild; Haberkorn, Uwe; Dimitrakopoulou-Strauss, Antonia; Reichert, Philipp; Barlogie, Bart; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hillengass, Jens; Rasche, Leo; Haas, Simon F; van Rhee, Frits; Rippe, Karsten; Raab, Marc S; Sauer, Sandra; Weinhold, Niels.
Afiliação
  • John L; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Poos AM; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brobeil A; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Schinke C; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Huhn S; Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Prokoph N; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Lutz R; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Wagner B; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Zangari M; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tirier SM; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Mallm JP; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Schumacher S; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Vonficht D; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Solé-Boldo L; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Quick S; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.
  • Steiger S; Single Cell Open Lab, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.
  • Przybilla MJ; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.
  • Bauer K; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany.
  • Baumann A; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ-ZMBH Alliance, Heidelberg, Germany.
  • Hemmer S; Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Rehnitz C; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Lückerath C; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.
  • Sachpekidis C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Mechtersheimer G; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.
  • Haberkorn U; Division Computational Genomics and Systems Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dimitrakopoulou-Strauss A; Wellcome Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
  • Reichert P; Single Cell Open Lab, German Cancer Research Center (DKFZ) and BioQuant, Heidelberg, Germany.
  • Barlogie B; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Müller-Tidow C; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Goldschmidt H; Department of Orthopedic Surgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Hillengass J; Department of Radiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Rasche L; Department of Radiology, Heidelberg University Hospital, Heidelberg, Germany.
  • Haas SF; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • van Rhee F; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rippe K; Department of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Raab MS; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Sauer S; Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany.
  • Weinhold N; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nat Commun ; 14(1): 5011, 2023 08 17.
Article em En | MEDLINE | ID: mdl-37591845
ABSTRACT
In multiple myeloma spatial differences in the subclonal architecture, molecular signatures and composition of the microenvironment remain poorly characterized. To address this shortcoming, we perform multi-region sequencing on paired random bone marrow and focal lesion samples from 17 newly diagnosed patients. Using single-cell RNA- and ATAC-seq we find a median of 6 tumor subclones per patient and unique subclones in focal lesions. Genetically identical subclones display different levels of spatial transcriptional plasticity, including nearly identical profiles and pronounced heterogeneity at different sites, which can include differential expression of immunotherapy targets, such as CD20 and CD38. Macrophages are significantly depleted in the microenvironment of focal lesions. We observe proportional changes in the T-cell repertoire but no site-specific expansion of T-cell clones in intramedullary lesions. In conclusion, our results demonstrate the relevance of considering spatial heterogeneity in multiple myeloma with potential implications for models of cell-cell interactions and disease progression.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
...